<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Neonatal pneumonia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Neonatal pneumonia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Neonatal pneumonia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael E Speer, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph A Garcia-Prats, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 19, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Pneumonia is an important cause of neonatal infection and accounts for significant morbidity and mortality, especially in developing countries [<a href="#rid1">1,2</a>].</p><p>The epidemiology, microbiology, clinical manifestations, diagnosis, and treatment of neonatal pneumonia are reviewed here. Neonatal sepsis is discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5046.html" rel="external">"Management and outcome of sepsis in term and late preterm neonates"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/88740.html" rel="external">"Clinical features and diagnosis of bacterial sepsis in preterm infants &lt;34 weeks gestation"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/89456.html" rel="external">"Treatment and prevention of bacterial sepsis in preterm infants &lt;34 weeks gestation"</a>.)</p><p></p><p class="headingAnchor" id="H219327208"><span class="h1">TIMING OF ONSET</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early-onset pneumonia</strong> – Early-onset pneumonia is variably defined as within 48 hours to six days of birth. For the purpose of this topic review, we define early-onset as before 72 hours of age.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Late-onset pneumonia</strong> – Late-onset pneumonia is generally defined as onset of symptoms at ≥72 hours of age.</p><p></p><p class="headingAnchor" id="H3"><span class="h1">ROUTES OF ACQUISITION</span><span class="headingEndMark"> — </span>The timing of onset and likely pathogens vary depending on the route of acquisition.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early-onset pneumonia</strong> – Early-onset pneumonia (ie, before 72 hours of age) is acquired from the mother by one of three routes:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intrauterine aspiration of infected amniotic fluid.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Transplacental transmission of organisms from the mother to the fetus through the placental circulation.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aspiration of infected amniotic fluid during or after birth. The neonate can aspirate vaginal colonizing organisms, leading to respiratory colonization and, in some cases, pneumonia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Late-onset pneumonia</strong> – Late-onset pneumonia (ie, at ≥72 hours of age) can occur in two settings:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neonates presenting from the community – Late-onset infections (including pneumonia) occurring in term and near-term newborns who were discharged home after the initial birth hospitalization are most commonly due to maternal vertical transmission, resulting in initial neonatal colonization that evolves into later infection. (See  <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Pathogenesis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neonates hospitalized since birth – Hospital-acquired late-onset infections (including pneumonia) in neonates who remain in the hospital since birth (eg, preterm infants) more commonly result from horizontal transmission from direct contact with care providers or environmental sources. Disruption of the intact skin or mucosa, which can be due to invasive devices (eg, endotracheal tubes, intravascular catheters), increases the risk of late-onset infection. (See  <a class="medical medical_review" href="/z/d/html/88740.html" rel="external">"Clinical features and diagnosis of bacterial sepsis in preterm infants &lt;34 weeks gestation", section on 'Late-onset sepsis (LOS)'</a>.)</p><p></p><p class="headingAnchor" id="H7"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>The pathologic changes vary depending on the type of organism. Bacterial pneumonia is characterized by inflammation of the pleura, infiltration or destruction of bronchopulmonary tissue, and leukocyte and fibrinous exudate within alveoli and the bronchi/bronchioles [<a href="#rid3">3</a>]. Bacteria often are seen within the interstitial spaces, alveoli, and bronchi/bronchioles [<a href="#rid4">4</a>]. Viruses typically cause an interstitial pneumonia.</p><p class="headingAnchor" id="H4043311907"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H125825190"><span class="h2">Incidence</span><span class="headingEndMark"> — </span>In resource-abundant settings, the estimated incidence of pneumonia is &lt;1 percent among full-term infants and up to 10 percent in preterm, extremely low birth weight infants (ie, birth weight &lt;1000 g) who require mechanical ventilation [<a href="#rid5">5-7</a>].</p><p>Pneumonia is a major cause of mortality among extremely low birth weight infants, accounting for nearly 30 percent of deaths in this population in one series [<a href="#rid8">8</a>].</p><p>In resource-limited settings, pneumonia is a major contributor to infant mortality. The World Health Organization estimated that in 2015, pneumonia caused &gt;900,000 deaths worldwide in children under five years old, with the majority of deaths occurring in infants &lt;1 year old [<a href="#rid9">9</a>]. In one study conducted in a rural area in central India, mortality secondary to pneumonia in the first month was 29 per 1000 live births; more than one-half of all pneumonia deaths in children occurred in newborns [<a href="#rid10">10</a>]. These figures may underestimate the burden of neonatal pneumonia in resource-limited settings because many newborns do not receive medical care.</p><p class="headingAnchor" id="H3528112393"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Risk factors vary depending on the timing of onset.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early-onset pneumonia</strong> – Risk factors associated with early-onset pneumonia are the same as those associated with early-onset sepsis and include [<a href="#rid3">3,6</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prematurity and low birth weight</p><p class="bulletIndent2"><span class="glyph">•</span>Maternal chorioamnionitis (also referred to as intraamniotic infection)</p><p class="bulletIndent2"><span class="glyph">•</span>Premature or prolonged rupture of membranes</p><p class="bulletIndent2"><span class="glyph">•</span>Maternal group B streptococcus colonization</p><p class="bulletIndent2"><span class="glyph">•</span>Maternal intrapartum fever</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Late-onset pneumonia</strong> – Risk factors associated with late-onset pneumonia include [<a href="#rid3">3,6,11</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prematurity and low birth weight</p><p class="bulletIndent2"><span class="glyph">•</span>Invasive mechanical ventilation, particularly for a prolonged duration</p><p class="bulletIndent2"><span class="glyph">•</span>Use of gastric acid blocking agents (eg, histamine type 2 (H2) blockers)</p><p class="bulletIndent2"><span class="glyph">•</span>Anomalies of the airway (eg, choanal atresia, tracheoesophageal fistula, and cystic adenomatoid malformations)</p><p class="bulletIndent2"><span class="glyph">•</span>Severe underlying pulmonary disease</p><p class="bulletIndent2"><span class="glyph">•</span>Prolonged hospitalization</p><p class="bulletIndent2"><span class="glyph">•</span>Neurologic impairment resulting in aspiration of gastrointestinal contents</p><p></p><p>Hospital-acquired viral infections occasionally are traced to poor handwashing or overcrowding [<a href="#rid12">12</a>]. </p><p class="headingAnchor" id="H8"><span class="h1">ETIOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bacterial pathogens</strong> – Group B streptococcus and <em>Escherichia</em> <em>coli</em> account for most cases of bacterial pneumonia in neonates [<a href="#rid2">2,6</a>]. Other important bacterial pathogens include <em>Klebsiella</em> spp, <em>Staphylococcus</em> <em>aureus</em>, <em>Streptococcus</em> <em>pneumoniae</em>, <em>Streptococcus</em> <em>pyogenes</em>, and <em>Chlamydia</em> <em>trachomatis</em> [<a href="#rid2">2</a>]. Gram-negative organisms (eg, <em>Serratia</em>, <em>Enterobacter</em>, <em>Pseudomonas</em>, <em>Citrobacter</em>) are increasingly recognized, particularly in preterm neonates with late-onset pneumonia [<a href="#rid13">13</a>]. <em>Listeria</em> <em>monocytogenes</em> and <em>Mycobacterium</em> <em>tuberculosis</em> are uncommon but important causes.</p><p></p><p class="bulletIndent1">Bacterial pathogens in early- and late-onset pneumonia are generally similar to those identified in early- and late-onset sepsis, as summarized in the table  (<a class="graphic graphic_table graphicRef61061" href="/z/d/graphic/61061.html" rel="external">table 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Etiologic agents'</a>.)</p><p></p><p class="bulletIndent1">Some bacterial pathogens have characteristic features:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>S</em>. <em>aureus</em> and <em>Klebsiella</em> <em>pneumoniae</em> are often associated with extensive tissue damage, abscess formation, and empyema [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>S</em>. <em>aureus</em>, <em>Klebsiella</em> <em>spp</em>, <em>E</em>. <em>coli</em>, <em>Serratia</em> <em>marcescens</em>, <em>Enterobacter</em> <em>cloacae</em>, <em>S</em>. <em>pneumoniae</em>, and <em>Pseudomonas</em> <em>aeruginosa</em> may cause pneumatoceles [<a href="#rid14">14-16</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>C</em>. <em>trachomatis</em> has a long incubation period and typically is associated with pneumonia occurring beyond two weeks of age. (See  <a class="medical medical_review" href="/z/d/html/4993.html" rel="external">"Chlamydia trachomatis infections in the newborn", section on 'Pneumonia'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>Citrobacter</em> <em>diversus</em>, frequently associated with brain abscesses in neonates, can also cause lung abscess [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1">One bacterial pathogen, <em>Ureaplasma</em> <em>urealyticum</em>, has been linked potentially to the development of bronchopulmonary dysplasia in preterm infants. This is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5508.html" rel="external">"<i>Mycoplasma hominis</i> and <i>Ureaplasma </i>infections", section on 'Neonatal disease'</a> and  <a class="medical medical_review" href="/z/d/html/4987.html" rel="external">"Bronchopulmonary dysplasia (BPD): Clinical features and diagnosis", section on 'Infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Viral pathogens</strong> – Viral lower respiratory tract infection in neonates can occur from:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Transplacental transmission (from a mother who acquires the infection in pregnancy)</p><p class="bulletIndent2"><span class="glyph">•</span>Perinatal transmission (from the mother at the time of birth), or</p><p class="bulletIndent2"><span class="glyph">•</span>Postnatal acquisition (from family members/caregivers who are in contact with the newborn or from nosocomial spread within the care unit) </p><p></p><p class="bulletIndent1">Important viral pathogens in the newborn include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Herpes simplex virus – Herpes simplex virus pneumonia occurs in 33 to 54 percent of disseminated herpes simplex virus infections and usually is fatal despite treatment [<a href="#rid17">17,18</a>]. (See  <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">"Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Disseminated disease'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cytomegalovirus (CMV), which can be acquired in utero (ie, congenital CMV) or postnatally (eg, from breast milk or transfusion). (See  <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">"Congenital cytomegalovirus infection: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5965.html" rel="external">"Overview of cytomegalovirus infections in children", section on 'Early postnatal infection'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Enterovirus and parechovirus, which tend to cause systemic illness (sepsis-like picture). (See  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Neonates'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Respiratory syncytial virus (RSV). (See  <a class="medical medical_review" href="/z/d/html/5994.html" rel="external">"Respiratory syncytial virus infection: Clinical features and diagnosis in infants and children"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). (See  <a class="medical medical_review" href="/z/d/html/127535.html" rel="external">"COVID-19: Overview of pregnancy issues", section on 'Risk of vertical transmission'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Other respiratory viral pathogens (eg, influenza virus, parainfluenza virus, adenovirus). (See  <a class="medical medical_review" href="/z/d/html/5973.html" rel="external">"Seasonal influenza in children: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5975.html" rel="external">"Parainfluenza viruses in children"</a> and  <a class="medical medical_review" href="/z/d/html/8339.html" rel="external">"Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fungal pathogens</strong> – <em>Candida</em> spp and other fungal pathogens are important pathogens causing systemic infections in neonates, particularly in extremely low birth weight infants [<a href="#rid19">19</a>]. Infants receiving prolonged antibiotic therapy and/or corticosteroids are at increased risk for invasive infection. (See  <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">"Clinical manifestations and diagnosis of Candida infection in neonates", section on 'Invasive infection'</a>.)</p><p></p><p class="bulletIndent1"><em>Aspergillosis</em> is a rare cause of neonatal pneumonia that is frequently fatal [<a href="#rid20">20</a>]. Aspergillus infection can occur in clusters, particularly during hospital renovations [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other pathogens</strong> – Occasionally, early-onset pneumonia is seen in patients with congenital toxoplasmosis and syphilis [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/z/d/html/14426.html" rel="external">"Congenital toxoplasmosis: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/14428.html" rel="external">"Congenital syphilis: Clinical manifestations, evaluation, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H20"><span class="h1">CLINICAL PRESENTATION</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early-onset pneumonia</strong> – Early-onset pneumonia presents with findings that may include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Respiratory distress, beginning at or soon after birth</p><p class="bulletIndent2"><span class="glyph">•</span>Apnea</p><p class="bulletIndent2"><span class="glyph">•</span>Temperature instability</p><p class="bulletIndent2"><span class="glyph">•</span>Tachycardia and/or poor perfusion, sometimes progressing to septic shock (see  <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">"Neonatal shock: Etiology, clinical manifestations, and evaluation"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Other nonspecific signs of infection (eg, lethargy, metabolic acidosis, abdominal distension)</p><p class="bulletIndent2"><span class="glyph">•</span>Newborns with severe infection may have associated persistent pulmonary hypertension (see  <a class="medical medical_review" href="/z/d/html/5045.html" rel="external">"Persistent pulmonary hypertension of the newborn (PPHN): Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent1">These signs are not specific for pneumonia, and respiratory distress also can be caused by noninfectious causes  (<a class="graphic graphic_table graphicRef56457" href="/z/d/graphic/56457.html" rel="external">table 2</a>). (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Late-onset pneumonia</strong> – Late-onset pneumonia is heralded by changes in the overall condition of the newborn. Nonspecific signs may include: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Apnea</p><p class="bulletIndent2"><span class="glyph">•</span>Tachypnea and/or respiratory distress </p><p class="bulletIndent2"><span class="glyph">•</span>Poor feeding and/or emesis</p><p class="bulletIndent2"><span class="glyph">•</span>Abdominal distention</p><p class="bulletIndent2"><span class="glyph">•</span>Jaundice, emesis, and </p><p class="bulletIndent2"><span class="glyph">•</span>Tachycardia and/or hemodynamic instability </p><p class="bulletIndent2"><span class="glyph">•</span>Ventilator-dependent infants may have increased oxygen and ventilator requirements or purulent tracheal secretions</p><p></p><p class="headingAnchor" id="H3361299969"><span class="h1">EVALUATION</span><span class="headingEndMark"> — </span>Neonates with suspected bacterial pneumonia should undergo evaluation including laboratory tests, cultures, and chest radiography. If viral infection is suspected, appropriate viral testing should be performed.</p><p class="headingAnchor" id="H4196244289"><span class="h2">Sepsis evaluation</span><span class="headingEndMark"> — </span>Because signs of pneumonia in neonates are nonspecific, neonates with sudden onset of respiratory distress or other signs of systemic illness should undergo a full sepsis evaluation, which at a minimum should include a blood culture. The diagnostic evaluation for suspected neonatal sepsis is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Laboratory tests'</a> and  <a class="medical medical_review" href="/z/d/html/88740.html" rel="external">"Clinical features and diagnosis of bacterial sepsis in preterm infants &lt;34 weeks gestation", section on 'Evaluation'</a>.)</p><p class="headingAnchor" id="H2732108789"><span class="h2">Microbiologic testing</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cultures</strong> – Cultures of blood and cerebrospinal fluid should be obtained. (See  <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Laboratory tests'</a> and  <a class="medical medical_review" href="/z/d/html/88740.html" rel="external">"Clinical features and diagnosis of bacterial sepsis in preterm infants &lt;34 weeks gestation", section on 'Symptomatic neonates'</a>.)</p><p></p><p class="bulletIndent1">In infants who are intubated, Gram stain and culture of tracheal aspirates should be performed [<a href="#rid23">23-26</a>]. In chronically ventilated patients, growth of bacteria from tracheal aspirate may represent true infection or colonization [<a href="#rid27">27</a>]. In this setting, polymicrobial growth, low levels of growth, and/or growth of nonpathogenic bacteria are more suggestive of contamination or colonization rather than infection. (See  <a class="medical medical_review" href="/z/d/html/6045.html" rel="external">"Tracheobronchitis associated with tracheostomy tubes and endotracheal intubation in children", section on 'Culture'</a>.)</p><p></p><p class="bulletIndent1">In patients with pleural effusions, if pleural fluid is sampled for therapeutic reasons, it can be sent for Gram stain and culture. It is generally unnecessary to perform pleural fluid sampling solely for the purpose of obtaining a culture.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Viral testing</strong> – If a viral etiology is suspected, testing should include polymerase chain reaction testing (ie, respiratory viral panel) and viral cultures. If a congenital or perinatally acquired infection is suspected (eg, congenital cytomegalovirus, herpes simplex virus), appropriate viral testing should be performed, as described separately. (See  <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">"Congenital cytomegalovirus infection: Clinical features and diagnosis", section on 'Approach to testing'</a> and  <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">"Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Detection of HSV'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Testing for </strong><strong><em>C</em></strong><strong>. </strong><strong><em>trachomatis</em></strong> – If <em>C</em>. <em>trachomatis</em> infection is suspected (eg, if the neonate was born to a mother with a history of untreated <em>C</em>. <em>trachomatis</em> infection or no prenatal care), testing should be performed using a nucleic acid amplification test on a nasopharyngeal sample, as discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4993.html" rel="external">"Chlamydia trachomatis infections in the newborn", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fungal cultures</strong> – If there is clinical suspicion for invasive fungal infection (eg, preterm neonate receiving broad-spectrum antibiotics), it may be appropriate to obtain fungal cultures in addition to bacterial cultures. This is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">"Clinical manifestations and diagnosis of Candida infection in neonates", section on 'Invasive infections'</a>.)</p><p></p><p class="headingAnchor" id="H1337887278"><span class="h2">Diagnostic imaging</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest radiography</strong> – The chest radiograph is the main diagnostic test for confirming the diagnosis of pneumonia. Bilateral pulmonary opacities or focal infiltrates with air bronchograms are the characteristic findings [<a href="#rid6">6,28,29</a>]. However, the radiographic findings are variable. Occasionally, the chest radiograph will be normal (eg, if obtained early in the course) [<a href="#rid30">30</a>]. In addition, the appearance can overlap with other types of neonatal lung disease. For example, some neonates may have diffuse hazy opacities that appear similar to respiratory distress syndrome in preterm infants [<a href="#rid31">31-33</a>]. Others may have coarse irregular opacities similar to the appearance of meconium aspiration syndrome [<a href="#rid29">29</a>]. The clinical context can generally distinguish between these diagnoses. In uncertain cases, the presence of pleural effusions can support the diagnosis of pneumonia since effusions are common in neonatal pneumonia and less common in respiratory distress syndrome or meconium aspiration syndrome [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lung ultrasound</strong> – In experienced hands, lung ultrasound has good sensitivity and specificity for diagnosing common neonatal respiratory diseases, including pneumonia [<a href="#rid34">34,35</a>]. The characteristic ultrasound findings of pneumonia in neonates are hypoechoic areas of consolidation with irregular margins and air bronchograms [<a href="#rid36">36</a>]. However, the diagnostic accuracy varies considerably depending on the experience and expertise of the operator. For this reason, lung ultrasound is not a routine part of the evaluation of neonates with suspected pneumonia.</p><p></p><p class="headingAnchor" id="H21"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of neonatal pneumonia is based upon a combination of clinical, radiographic, and microbiologic findings. Characteristic chest radiograph findings (ie, bilateral pulmonary opacities or focal infiltrates with air bronchograms) in the appropriate clinical setting (ie, acute onset of respiratory symptoms and other signs of infection) are generally sufficient to establish the diagnosis. Positive cultures from blood or tracheal aspirates help confirm the diagnosis, but they are not required. Similarly, abnormal inflammatory markers (eg, high or low white blood cell count) are supportive findings but are not required.</p><p class="headingAnchor" id="H3566043123"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of neonatal pneumonia includes other causes of respiratory distress that may present in the newborn period, including  (<a class="graphic graphic_table graphicRef56457" href="/z/d/graphic/56457.html" rel="external">table 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Disorders of transition (eg, transient tachypnea or the newborn, respiratory distress syndrome) (see  <a class="medical medical_review" href="/z/d/html/4964.html" rel="external">"Overview of neonatal respiratory distress and disorders of transition"</a> and  <a class="medical medical_review" href="/z/d/html/5066.html" rel="external">"Transient tachypnea of the newborn"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Meconium aspiration syndrome (see  <a class="medical medical_review" href="/z/d/html/4971.html" rel="external">"Meconium aspiration syndrome: Pathophysiology, clinical manifestations, and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pneumothorax (see  <a class="medical medical_review" href="/z/d/html/4995.html" rel="external">"Pulmonary air leak in the newborn", section on 'Pneumothorax'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Congenital malformations (eg, congenital diaphragmatic hernia, congenital pulmonary airway malformation) (see  <a class="medical medical_review" href="/z/d/html/4963.html" rel="external">"Congenital diaphragmatic hernia in the neonate"</a> and  <a class="medical medical_review" href="/z/d/html/6346.html" rel="external">"Congenital pulmonary airway malformation"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Congenital heart disease (large ventricular septal defect, total anomalous pulmonary venous connection, patent ductus arteriosus, truncus arteriosus) (see  <a class="medical medical_review" href="/z/d/html/5774.html" rel="external">"Identifying newborns with critical congenital heart disease", section on 'Respiratory symptoms'</a>)</p><p></p><p>The clinical history, microbiologic testing, and radiographic findings can generally distinguish pneumonia from other causes of respiratory distress.</p><p class="headingAnchor" id="H24"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H1147021371"><span class="h2">Supportive care</span><span class="headingEndMark"> — </span>Neonates with pneumonia can deteriorate rapidly. Thus, neonates with respiratory compromise should be managed in the neonatal intensive care unit setting where they can receive close cardiopulmonary monitoring and support. The following supportive measures are important components of management:</p><p class="bulletIndent1"><span class="glyph">●</span>Maintaining a neutral thermal environment </p><p class="bulletIndent1"><span class="glyph">●</span>Maintaining adequate oxygenation and perfusion (see  <a class="medical medical_review" href="/z/d/html/5067.html" rel="external">"Respiratory support, oxygen delivery, and oxygen monitoring in the newborn"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Prevention of hypoglycemia and metabolic acidosis (see  <a class="medical medical_review" href="/z/d/html/101425.html" rel="external">"Management and outcome of neonatal hypoglycemia"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Maintenance of normal fluid and electrolyte status (see  <a class="medical medical_review" href="/z/d/html/5065.html" rel="external">"Fluid and electrolyte therapy in newborns"</a>)</p><p></p><p>Severely ill patients may require ventilatory, volume, and/or vasopressor support to maintain adequate oxygenation and perfusion. (See  <a class="medical medical_review" href="/z/d/html/5032.html" rel="external">"Overview of mechanical ventilation in neonates"</a> and  <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">"Neonatal shock: Etiology, clinical manifestations, and evaluation"</a>.)</p><p class="headingAnchor" id="H25"><span class="h2">Bacterial pneumonia</span></p><p class="headingAnchor" id="H364259994"><span class="h3">Initial empiric therapy</span><span class="headingEndMark"> — </span>Empiric parenteral antibiotic therapy is started pending culture results. The choice of empiric regimen is based upon whether the infection is of early or late onset.</p><p>Once a specific organism is identified, therapy is modified according to the susceptibility pattern. (See <a class="local">'Definitive therapy'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early-onset pneumonia</strong> – For early-onset pneumonia (ie, before 72 hours of age), we suggest initial empiric coverage with <a class="drug drug_pediatric" data-topicid="12683" href="/z/d/drug information/12683.html" rel="external">ampicillin</a> and <a class="drug drug_pediatric" data-topicid="13332" href="/z/d/drug information/13332.html" rel="external">gentamicin</a>. However, local antibiotic susceptibility patterns should also be considered. For example, in centers with a high prevalence of gentamicin resistance among gram-negative isolates, an alternative aminoglycoside (eg, <a class="drug drug_pediatric" data-topicid="12541" href="/z/d/drug information/12541.html" rel="external">amikacin</a>) should be used [<a href="#rid37">37,38</a>].</p><p></p><p class="bulletIndent1">Dosing of <a class="drug drug_pediatric" data-topicid="12683" href="/z/d/drug information/12683.html" rel="external">ampicillin</a> and <a class="drug drug_pediatric" data-topicid="13332" href="/z/d/drug information/13332.html" rel="external">gentamicin</a> is based upon the infant's weight, renal function, postnatal age, and postmenstrual age [<a href="#rid39">39</a>]. Refer to the drug monographs for details.</p><p></p><p class="bulletIndent1"><a class="drug drug_pediatric" data-topicid="12683" href="/z/d/drug information/12683.html" rel="external">Ampicillin</a> is effective against group B streptococcus, most other strains of streptococci, <em>L</em>. <em>monocytogenes</em>, and some gram-negative bacteria. Ampicillin plus an aminoglycoside also has synergistic activity against many of these organisms [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1">Third-generation cephalosporins, although active against many gram-negative organisms, should generally <strong>not</strong> be used for suspected early-onset sepsis or pneumonia. Gram-negative bacilli can rapidly develop resistance to cephalosporins by either inducible or chromosomally mediated beta-lactamase activity [<a href="#rid41">41,42</a>]. In addition, a large observational study found that the risk of death from early-onset sepsis was increased in neonates who received <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">cefotaxime</a> as initial empiric treatment compared with those who received <a class="drug drug_pediatric" data-topicid="13332" href="/z/d/drug information/13332.html" rel="external">gentamicin</a> [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Late-onset pneumonia</strong> – The choice of empiric therapy for late-onset pneumonia is influenced by the clinical setting (ie, whether the neonate has been hospitalized since birth or is presenting from the community) and local susceptibility patterns.</p><p></p><p class="bulletIndent1">For most infants ≥72 hours old, we suggest an empiric regimen that includes:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_pediatric" data-topicid="12683" href="/z/d/drug information/12683.html" rel="external">Ampicillin</a> <strong>or</strong> <a class="drug drug_pediatric" data-topicid="12874" href="/z/d/drug information/12874.html" rel="external">vancomycin</a>, <strong>plus</strong></p><p class="bulletIndent2"><span class="glyph">•</span>An aminoglycoside (typically <a class="drug drug_pediatric" data-topicid="13332" href="/z/d/drug information/13332.html" rel="external">gentamicin</a>) <strong>or</strong> an extended-spectrum cephalosporin (eg, <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">cefotaxime</a> [where available], <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">ceftazidime</a>, or <a class="drug drug_pediatric" data-topicid="13126" href="/z/d/drug information/13126.html" rel="external">cefepime</a>)</p><p></p><p class="bulletIndent1"><a class="drug drug_pediatric" data-topicid="12874" href="/z/d/drug information/12874.html" rel="external">Vancomycin</a> should generally be included in the regimen for neonates with hospital-acquired pneumonia (eg, preterm neonates who remain hospitalized since birth) and for those presenting from the community in settings where the prevalence of methicillin-resistance among <em>S</em>. <em>aureus</em> isolates is high (eg, &gt;10 percent). If preliminary culture results indicate <em>S</em>. <em>aureus</em> infection, <a class="drug drug_pediatric" data-topicid="12626" href="/z/d/drug information/12626.html" rel="external">nafcillin</a> should be added to the empiric regimen pending antimicrobial susceptibility results. Including both vancomycin and nafcillin in the empiric regimen optimizes activity against both methicillin-resistant and methicillin-susceptible <em>S</em>. <em>aureus</em>. This issue is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/6057.html" rel="external">"<i>Staphylococcus aureus </i>in children: Overview of treatment of invasive infections", section on 'Empiric antimicrobial therapy'</a>.)</p><p></p><p class="bulletIndent1">Dosing of these medications is based upon the infant's weight, renal function, postnatal age, and postmenstrual age. Refer to the drug monographs for details. Once a specific organism is identified, therapy is modified according to the susceptibility pattern. (See <a class="local">'Definitive therapy'</a> below.)</p><p></p><p class="headingAnchor" id="H2976472344"><span class="h3">Definitive therapy</span></p><p class="headingAnchor" id="H1688872763"><span class="h4">Culture-positive pneumonia</span><span class="headingEndMark"> — </span>For infants who have microbiologically proven pneumonia (ie, based upon positive cultures from tracheal aspirates and/or positive blood cultures in conjunction with clinical evidence of pneumonia), antibiotic therapy should be tailored based upon susceptibility testing of the isolated pathogen.</p><p>The usual treatment duration for uncomplicated pneumonia is 7 to 10 days.</p><p>The agent used depends upon the isolated pathogen:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Group B streptococcus</strong> – Penicillin or <a class="drug drug_pediatric" data-topicid="12683" href="/z/d/drug information/12683.html" rel="external">ampicillin</a> are the preferred agents for treatment of group B streptococcus, as summarized in the table  (<a class="graphic graphic_table graphicRef66906" href="/z/d/graphic/66906.html" rel="external">table 3</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5961.html" rel="external">"Group B streptococcal infection in neonates and young infants", section on 'Definitive therapy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>E</em></strong><strong>. </strong><strong><em>coli</em></strong> – In patients with ampicillin-sensitive <em>E</em>. <em>coli</em> infections, <a class="drug drug_pediatric" data-topicid="12683" href="/z/d/drug information/12683.html" rel="external">ampicillin</a> monotherapy is administered for definitive therapy.</p><p></p><p class="bulletIndent1">For patients with ampicillin-resistant <em>E</em>. <em>coli</em>, the choice of definitive therapy is based upon the susceptibility profile. An expanded-spectrum cephalosporin (eg, <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">cefotaxime</a> [where available], <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">ceftazidime</a>, or <a class="drug drug_pediatric" data-topicid="13126" href="/z/d/drug information/13126.html" rel="external">cefepime</a>) is often employed if the isolate is susceptible or an appropriate aminoglycoside.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other gram-negative bacteria</strong> – Antimicrobial treatment of infections caused by <em>Klebsiella</em>, <em>Enterobacter</em>, <em>Serratia</em>, <em>Pseudomonas</em>, or other gram-negatives should be selected based upon the susceptibility profile of the organism. Single-agent therapy is sufficient in most cases.</p><p></p><p class="bulletIndent1">Infections caused by multidrug-resistant, gram-negative bacilli, including those caused by extended-spectrum beta-lactamase-producing organisms or those with hyperproduction of beta-lactamases, should be treated with <a class="drug drug_pediatric" data-topicid="12583" href="/z/d/drug information/12583.html" rel="external">meropenem</a> [<a href="#rid44">44</a>]. Consultation with an infectious disease specialist is advised.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>S</em></strong><strong>. </strong><strong><em>aureus</em></strong> – Treatment of methicillin-susceptible <em>S</em>. <em>aureus</em> infection should be completed with <a class="drug drug_pediatric" data-topicid="12626" href="/z/d/drug information/12626.html" rel="external">nafcillin</a>. <a class="drug drug_pediatric" data-topicid="13124" href="/z/d/drug information/13124.html" rel="external">Cefazolin</a> is a reasonable alternative. (See  <a class="medical medical_review" href="/z/d/html/5967.html" rel="external">"Staphylococcus aureus bacteremia in children: Management and outcome"</a>.)</p><p></p><p class="bulletIndent1">Treatment of methicillin-resistant <em>S</em>. <em>aureus</em> should be completed with <a class="drug drug_pediatric" data-topicid="12874" href="/z/d/drug information/12874.html" rel="external">vancomycin</a>. (See  <a class="medical medical_review" href="/z/d/html/6057.html" rel="external">"<i>Staphylococcus aureus </i>in children: Overview of treatment of invasive infections", section on 'Treatment of neonates'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>C</em></strong><strong>. </strong><strong><em>trachomatis</em></strong> – Oral <a class="drug drug_pediatric" data-topicid="12937" href="/z/d/drug information/12937.html" rel="external">azithromycin</a> is the preferred treatment for neonatal <em>C</em>. <em>trachomatis</em> infections, as discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4993.html" rel="external">"Chlamydia trachomatis infections in the newborn", section on 'Treatment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>L</em></strong><strong>. </strong><strong><em>monocytogenes</em></strong> – Treatment of <em>L</em>. <em>monocytogenes</em> infections in neonates is summarized in the table  (<a class="graphic graphic_table graphicRef122593" href="/z/d/graphic/122593.html" rel="external">table 4</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1303.html" rel="external">"Treatment and prevention of Listeria monocytogenes infection", section on 'Neonates'</a>.)</p><p></p><p class="headingAnchor" id="H3028581850"><span class="h4">Presumed bacterial pneumonia</span><span class="headingEndMark"> — </span>For neonates who are diagnosed clinically with presumed bacterial pneumonia based upon consistent clinical and radiographic findings but who have negative cultures (including blood, cerebrospinal fluid, and, if intubated, tracheal aspirate), empiric parenteral antibiotic therapy is continued for at least 48 to 72 hours. Ongoing clinical assessment during this period determines whether further treatment is warranted. If the clinical course and radiographic findings are highly suggestive of pneumonia, antibiotic treatment is continued for 7 to 10 days. If the findings are not suggestive of pneumonia or an alternative etiology is identified, antibiotic therapy should be discontinued, as discussed in the next section.</p><p class="headingAnchor" id="H2029674119"><span class="h4">Unlikely bacterial pneumonia</span><span class="headingEndMark"> — </span>Empiric antibiotics are initiated in some infants due to abnormal chest radiograph findings and/or mild to moderate symptoms that subsequently resolve. In some cases, an alternative etiology for the symptoms is identified (eg, a viral infection or retained fetal lung fluid). In these neonates, empiric antibiotic therapy should be discontinued after 48 hours if the cultures are negative since bacterial pneumonia is unlikely in this setting.</p><p class="headingAnchor" id="H28"><span class="h2">Viral pneumonia</span><span class="headingEndMark"> — </span>Treatments for specific viral etiologies of neonatal pneumonia are discussed in separate topic reviews:</p><p class="bulletIndent1"><span class="glyph">●</span>Herpes simplex virus – Treatment is according to the recommendations for disseminated disease (see  <a class="medical medical_review" href="/z/d/html/6040.html" rel="external">"Neonatal herpes simplex virus infection: Management and prevention", section on 'Initial antiviral therapy'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Congenital cytomegalovirus (see  <a class="medical medical_review" href="/z/d/html/98188.html" rel="external">"Congenital cytomegalovirus infection: Management and outcome", section on 'Antiviral treatment'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Respiratory syncytial virus and other viral lower respiratory tract infections (see  <a class="medical medical_review" href="/z/d/html/6001.html" rel="external">"Respiratory syncytial virus infection: Treatment in infants and children"</a> and  <a class="medical medical_review" href="/z/d/html/6020.html" rel="external">"Bronchiolitis in infants and children: Treatment, outcome, and prevention"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (see  <a class="medical medical_review" href="/z/d/html/129846.html" rel="external">"COVID-19: Intrapartum and postpartum issues", section on 'Care of newborns of infected mothers'</a>)</p><p></p><p class="headingAnchor" id="H31"><span class="h1">OUTCOME</span><span class="headingEndMark"> — </span>The prognosis of neonatal pneumonia depends upon the severity of the disease, gestational age of the patient, underlying medical conditions, and infecting organism. Most term neonates managed in resource-abundant settings recover well without long-term sequelae [<a href="#rid3">3</a>]. Preterm infants and neonates with preexisting lung disease (eg, bronchopulmonary dysplasia) or immune deficiency are at increased risk of morbidity and mortality [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H2114404157"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110817.html" rel="external">"Society guideline links: Sepsis in neonates"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/110776.html" rel="external">"Society guideline links: Pediatric pneumonia"</a>.)</p><p class="headingAnchor" id="H2128161"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incidence</strong> – Pneumonia is a major contributor to infant mortality worldwide. In resource-abundant countries, the estimated incidence of pneumonia in full-term infants is &lt;1 percent and up to 10 percent in extremely preterm infants who require mechanical ventilation. (See <a class="local">'Introduction'</a> above and <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing of onset</strong> – Neonatal pneumonia can be classified by the timing of onset as follows (see <a class="local">'Timing of onset'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Early-onset pneumonia (before 72 hours of age), which is generally acquired from the mother during labor or delivery. (See <a class="local">'Routes of acquisition'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Late-onset pneumonia (at ≥72 hours of age) also can be caused by maternal transmission. However, in neonates who remain hospitalized since birth (eg, preterm infants), late-onset infection more commonly results from direct contact with care providers or environmental sources (ie, hospital-acquired infection). (See <a class="local">'Routes of acquisition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Bacterial pathogens</strong> – Group B streptococcus and <em>Escherichia</em> <em>coli</em> account for most cases of bacterial pneumonia in neonates. Other important bacterial pathogens are summarized in the table  (<a class="graphic graphic_table graphicRef61061" href="/z/d/graphic/61061.html" rel="external">table 1</a>). (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Viral pathogens</strong> – Important viral causes of respiratory tract infections in the newborn include herpes simplex virus, cytomegalovirus, enterovirus, parechovirus, respiratory syncytial virus (RSV), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and other respiratory viral pathogens (eg, influenza virus, parainfluenza virus, adenovirus). (See <a class="local">'Etiology'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fungal pathogens</strong> – <em>Candida</em> spp and other fungal pathogens are important pathogens causing systemic infections in extremely low birth weight infants. (See  <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">"Clinical manifestations and diagnosis of Candida infection in neonates", section on 'Invasive infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> – Early-onset pneumonia commonly presents with respiratory distress beginning at or soon after birth. Other clinical manifestations, also seen in late-onset disease, are nonspecific and include temperature instability, apnea, lethargy, tachycardia, poor perfusion, tachypnea, and poor feeding. (See <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – Neonates with suspected bacterial pneumonia should undergo evaluation including laboratory tests, cultures, and chest radiography. If viral infection is suspected, appropriate viral testing should be performed. (See <a class="local">'Evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of neonatal pneumonia is based upon a combination of clinical, radiographic, and microbiologic findings. Characteristic chest radiograph findings (ie, bilateral pulmonary opacities or focal infiltrates with air bronchograms) in the appropriate clinical setting (ie, acute onset of respiratory symptoms and other signs of infection) are generally sufficient to establish the diagnosis. Positive cultures from blood or tracheal aspirates help confirm the diagnosis, but they are not required. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of neonatal pneumonia includes other causes of respiratory distress that may present in the newborn period, including  (<a class="graphic graphic_table graphicRef56457" href="/z/d/graphic/56457.html" rel="external">table 2</a>) (see <a class="local">'Differential diagnosis'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Disorders of transition (eg, transient tachypnea or the newborn, respiratory distress syndrome) (see  <a class="medical medical_review" href="/z/d/html/5066.html" rel="external">"Transient tachypnea of the newborn"</a> and  <a class="medical medical_review" href="/z/d/html/5055.html" rel="external">"Respiratory distress syndrome (RDS) in the newborn: Clinical features and diagnosis"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Meconium aspiration syndrome (see  <a class="medical medical_review" href="/z/d/html/4971.html" rel="external">"Meconium aspiration syndrome: Pathophysiology, clinical manifestations, and diagnosis"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Pneumothorax (see  <a class="medical medical_review" href="/z/d/html/4995.html" rel="external">"Pulmonary air leak in the newborn"</a> and  <a class="medical medical_review" href="/z/d/html/4995.html" rel="external">"Pulmonary air leak in the newborn", section on 'Pneumothorax'</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Congenital malformations (eg, congenital diaphragmatic hernia, congenital pulmonary airway malformation) (see  <a class="medical medical_review" href="/z/d/html/4963.html" rel="external">"Congenital diaphragmatic hernia in the neonate"</a> and  <a class="medical medical_review" href="/z/d/html/6346.html" rel="external">"Congenital pulmonary airway malformation"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Congenital heart disease (large ventricular septal defect, total anomalous pulmonary venous connection, patent ductus arteriosus, truncus arteriosus) (see  <a class="medical medical_review" href="/z/d/html/5774.html" rel="external">"Identifying newborns with critical congenital heart disease"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management </strong>– Neonates with pneumonia can deteriorate rapidly. Thus, neonates with respiratory compromise should be managed in the neonatal intensive care unit setting where they can receive close cardiopulmonary monitoring and support. (See <a class="local">'Supportive care'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Empiric therapy</strong> – Infants with pneumonia require empiric antibiotic therapy pending culture results. The choice of empiric antibiotic regimen is based upon the most likely pathogen, which varies depending upon timing of onset (early versus late onset) and clinical setting.</p><p></p><p class="bulletIndent2">For most neonates with <strong>early-onset pneumonia</strong> (before 72 hours of age), we suggest initial empiric therapy with <a class="drug drug_pediatric" data-topicid="12683" href="/z/d/drug information/12683.html" rel="external">ampicillin</a> and <a class="drug drug_pediatric" data-topicid="13332" href="/z/d/drug information/13332.html" rel="external">gentamicin</a> (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Initial empiric therapy'</a> above.)</p><p></p><p class="bulletIndent2">For most neonates with <strong>late-onset pneumonia</strong> (at ≥72 hours of age), we suggest an empiric regimen that includes (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_pediatric" data-topicid="12683" href="/z/d/drug information/12683.html" rel="external">Ampicillin</a> <strong>or</strong> <a class="drug drug_pediatric" data-topicid="12874" href="/z/d/drug information/12874.html" rel="external">vancomycin</a>, <strong>plus</strong></p><p class="bulletIndent3"><span class="glyph">-</span>An aminoglycoside (typically <a class="drug drug_pediatric" data-topicid="13332" href="/z/d/drug information/13332.html" rel="external">gentamicin</a>) <strong>or</strong> an extended-spectrum cephalosporin (eg, <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">cefotaxime</a> [where available], <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">ceftazidime</a>, or <a class="drug drug_pediatric" data-topicid="13126" href="/z/d/drug information/13126.html" rel="external">cefepime</a>)</p><p></p><p class="bulletIndent2">A vancomycin-containing regimen is appropriate for neonates with hospital-acquired pneumonia (eg, preterm neonates who remain hospitalized since birth) and for those presenting from the community in settings where the prevalence of methicillin-resistance among <em>Staphylococcus</em> <em>aureus</em> isolates is high (eg, &gt;10 percent). (See <a class="local">'Initial empiric therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Definitive therapy</strong> – When results of microbiologic tests are available, antibiotic therapy is directed toward the specific pathogen. The usual treatment duration for uncomplicated pneumonia is 7 to 10 days. (See <a class="local">'Definitive therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis</strong> – The prognosis of neonatal pneumonia depends upon the severity of the disease, gestational age of the patient, underlying medical conditions, and infecting organism. Most term neonates managed in resource-abundant settings recover well without long-term sequelae. (See <a class="local">'Outcome'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Stoll BJ. The global impact of neonatal infection. Clin Perinatol 1997; 24:1.</a></li><li><a class="nounderline abstract_t">Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal Neonatal Ed 2005; 90:F211.</a></li><li class="breakAll">Barnett EB, Klein JO. Bacterial indections of the respiratory tract. In: Infectious Diseases of the Fetus and Newborn, 8th, Wilson CB, Nizet V, Maldonado YA, Remmington JS, Klein JO (Eds), Elsevier (Saunders), Philadelphia, PA 2016. p.272.</li><li><a class="nounderline abstract_t">DAVIES PA, AHERNE W. Congenital pneumonia. Arch Dis Child 1962; 37:598.</a></li><li><a class="nounderline abstract_t">Nissen MD. Congenital and neonatal pneumonia. Paediatr Respir Rev 2007; 8:195.</a></li><li><a class="nounderline abstract_t">Hooven TA, Polin RA. Pneumonia. Semin Fetal Neonatal Med 2017; 22:206.</a></li><li><a class="nounderline abstract_t">Consortium on Safe Labor, Hibbard JU, Wilkins I, et al. Respiratory morbidity in late preterm births. JAMA 2010; 304:419.</a></li><li><a class="nounderline abstract_t">Barton L, Hodgman JE, Pavlova Z. Causes of death in the extremely low birth weight infant. Pediatrics 1999; 103:446.</a></li><li><a class="nounderline abstract_t">GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388:1459.</a></li><li><a class="nounderline abstract_t">Bang AT, Bang RA, Morankar VP, et al. Pneumonia in neonates: can it be managed in the community? Arch Dis Child 1993; 68:550.</a></li><li><a class="nounderline abstract_t">Santos VS, Freire MS, Santana RNS, et al. Association between histamine-2 receptor antagonists and adverse outcomes in neonates: A systematic review and meta-analysis. PLoS One 2019; 14:e0214135.</a></li><li><a class="nounderline abstract_t">Harbarth S, Sudre P, Dharan S, et al. Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol 1999; 20:598.</a></li><li><a class="nounderline abstract_t">Shane AL, Stoll BJ. Neonatal sepsis: progress towards improved outcomes. J Infect 2014; 68 Suppl 1:S24.</a></li><li><a class="nounderline abstract_t">Shamir R, Horev G, Merlob P, Nutman J. Citrobacter diversus lung abscess in a preterm infant. Pediatr Infect Dis J 1990; 9:221.</a></li><li><a class="nounderline abstract_t">Khan EA, Wafelman LS, Garcia-Prats JA, Taber LH. Serratia marcescens pneumonia, empyema and pneumatocele in a preterm neonate. Pediatr Infect Dis J 1997; 16:1003.</a></li><li><a class="nounderline abstract_t">Glustein JZ, Kaplan M. Enterobacter cloacae causing pneumatocele in a neonate. Acta Paediatr 1994; 83:990.</a></li><li><a class="nounderline abstract_t">Barker JA, McLean SD, Jordan GD, et al. Primary neonatal herpes simplex virus pneumonia. Pediatr Infect Dis J 1990; 9:285.</a></li><li><a class="nounderline abstract_t">Campbell JR. Neonatal pneumonia. Semin Respir Infect 1996; 11:155.</a></li><li><a class="nounderline abstract_t">Narang A, Agrawal PB, Chakrabarti A, Kumar P. Epidemiology of systemic candidiasis in a tertiary care neonatal unit. J Trop Pediatr 1998; 44:104.</a></li><li><a class="nounderline abstract_t">Rowen JL, Atkins JT, Levy ML, et al. Invasive fungal dermatitis in the &lt; or = 1000-gram neonate. Pediatrics 1995; 95:682.</a></li><li><a class="nounderline abstract_t">Krasinski K, Holzman RS, Hanna B, et al. Nosocomial fungal infection during hospital renovation. Infect Control 1985; 6:278.</a></li><li><a class="nounderline abstract_t">Edell DS, Davidson JJ, Mulvihill DM, Majure M. A common presentation of an uncommon cause of neonatal respiratory distress: pneumonia alba. Pediatr Pulmonol 1993; 15:376.</a></li><li><a class="nounderline abstract_t">Sherman MP, Goetzman BW, Ahlfors CE, Wennberg RP. Tracheal asiration and its clinical correlates in the diagnosis of congenital pneumonia. Pediatrics 1980; 65:258.</a></li><li><a class="nounderline abstract_t">Katayama Y, Minami H, Enomoto M, et al. Usefulness of Gram staining of tracheal aspirates in initial therapy for ventilator-associated pneumonia in extremely preterm neonates. J Perinatol 2010; 30:270.</a></li><li><a class="nounderline abstract_t">Booth GR, Al-Hosni M, Ali A, Keenan WJ. The utility of tracheal aspirate cultures in the immediate neonatal period. J Perinatol 2009; 29:493.</a></li><li><a class="nounderline abstract_t">Ruderman JW, Srugo I, Morgan MA, et al. Pneumonia in the neonatal intensive care unit. Diagnosis by quantitative bacterial tracheal aspirate cultures. J Perinatol 1994; 14:182.</a></li><li><a class="nounderline abstract_t">Willson DF, Conaway M, Kelly R, Hendley JO. The lack of specificity of tracheal aspirates in the diagnosis of pulmonary infection in intubated children. Pediatr Crit Care Med 2014; 15:299.</a></li><li><a class="nounderline abstract_t">Haney PJ, Bohlman M, Sun CC. Radiographic findings in neonatal pneumonia. AJR Am J Roentgenol 1984; 143:23.</a></li><li><a class="nounderline abstract_t">Liszewski MC, Lee EY. Neonatal Lung Disorders: Pattern Recognition Approach to Diagnosis. AJR Am J Roentgenol 2018; 210:964.</a></li><li><a class="nounderline abstract_t">Cleveland RH. A radiologic update on medical diseases of the newborn chest. Pediatr Radiol 1995; 25:631.</a></li><li><a class="nounderline abstract_t">Hemming VG, McCloskey DW, Hill HR. Pneumonia in the neonate associated with group B streptococcal septicemia. Am J Dis Child 1976; 130:1231.</a></li><li><a class="nounderline abstract_t">Speer M, Rosan RC, Rudolph AJ. Hemophilus influenzae infection in the neonate mimicking respiratory distress syndrome. J Pediatr 1978; 93:295.</a></li><li><a class="nounderline abstract_t">Bortolussi R, Thompson TR, Ferrieri P. Early-onset pneumococcal sepsis in newborn infants. Pediatrics 1977; 60:352.</a></li><li><a class="nounderline abstract_t">Sharma D, Farahbakhsh N. Role of chest ultrasound in neonatal lung disease: a review of current evidences. J Matern Fetal Neonatal Med 2019; 32:310.</a></li><li><a class="nounderline abstract_t">Kurepa D, Zaghloul N, Watkins L, Liu J. Neonatal lung ultrasound exam guidelines. J Perinatol 2018; 38:11.</a></li><li><a class="nounderline abstract_t">Liu J, Liu F, Liu Y, et al. Lung ultrasonography for the diagnosis of severe neonatal pneumonia. Chest 2014; 146:383.</a></li><li><a class="nounderline abstract_t">Hasvold J, Bradford L, Nelson C, et al. Gentamicin resistance among Escherichia coli strains isolated in neonatal sepsis. J Neonatal Perinatal Med 2013; 6:173.</a></li><li><a class="nounderline abstract_t">Muller-Pebody B, Johnson AP, Heath PT, et al. Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed 2011; 96:F4.</a></li><li class="breakAll">American Academy of Pediatrics. Tables of antibacterial drug dosages. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, 2021. p.876.</li><li><a class="nounderline abstract_t">Cooper MD, Keeney RE, Lyons SF, Cheatle EL. Synergistic effects of ampicillin-aminoglycoside combinations on group B streptococci. Antimicrob Agents Chemother 1979; 15:484.</a></li><li><a class="nounderline abstract_t">Edwards MS. Antibacterial therapy in pregnancy and neonates. Clin Perinatol 1997; 24:251.</a></li><li><a class="nounderline abstract_t">Gustaferro CA, Steckelberg JM. Cephalosporin antimicrobial agents and related compounds. Mayo Clin Proc 1991; 66:1064.</a></li><li><a class="nounderline abstract_t">Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006; 117:67.</a></li><li class="breakAll">American Academy of Pediatrics. Serious bacterial infections caused by Enterobacteriaceae (with emphasis on septicemia and meniningitis in neonates). In: Red Book: 2018 Report of the Committee on Infectious Disease, 31st Ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Itasca, IL 2018. p.328.</li></ol></div><div id="topicVersionRevision">Topic 5004 Version 36.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9099499" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The global impact of neonatal infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15846010" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Neonatal pneumonia in developing countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15846010" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Neonatal pneumonia in developing countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14025426" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Congenital pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17868917" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Congenital and neonatal pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28343909" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20664042" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Respiratory morbidity in late preterm births.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9925839" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Causes of death in the extremely low birth weight infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27733281" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8323354" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pneumonia in neonates: can it be managed in the community?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30947259" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Association between histamine-2 receptor antagonists and adverse outcomes in neonates: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10501256" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24140138" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Neonatal sepsis: progress towards improved outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2336304" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Citrobacter diversus lung abscess in a preterm infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9380455" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Serratia marcescens pneumonia, empyema and pneumatocele in a preterm neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7819699" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Enterobacter cloacae causing pneumatocele in a neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2159613" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Primary neonatal herpes simplex virus pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8883173" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Neonatal pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9604600" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Epidemiology of systemic candidiasis in a tertiary care neonatal unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7724303" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Invasive fungal dermatitis in the&lt;or = 1000-gram neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3847404" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Nosocomial fungal infection during hospital renovation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8337016" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A common presentation of an uncommon cause of neonatal respiratory distress: pneumonia alba.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7354971" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Tracheal asiration and its clinical correlates in the diagnosis of congenital pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19798042" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Usefulness of Gram staining of tracheal aspirates in initial therapy for ventilator-associated pneumonia in extremely preterm neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19339985" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The utility of tracheal aspirate cultures in the immediate neonatal period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8064419" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Pneumonia in the neonatal intensive care unit. Diagnosis by quantitative bacterial tracheal aspirate cultures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24614608" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The lack of specificity of tracheal aspirates in the diagnosis of pulmonary infection in intubated children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6610324" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Radiographic findings in neonatal pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29489412" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Neonatal Lung Disorders: Pattern Recognition Approach to Diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8570317" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A radiologic update on medical diseases of the newborn chest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/790940" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pneumonia in the neonate associated with group B streptococcal septicemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/307594" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Hemophilus influenzae infection in the neonate mimicking respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19725" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Early-onset pneumococcal sepsis in newborn infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28870125" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Role of chest ultrasound in neonatal lung disease: a review of current evidences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29144490" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Neonatal lung ultrasound exam guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24833216" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Lung ultrasonography for the diagnosis of severe neonatal pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24246520" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Gentamicin resistance among Escherichia coli strains isolated in neonatal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20584804" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Empirical treatment of neonatal sepsis: are the current guidelines adequate?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20584804" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Empirical treatment of neonatal sepsis: are the current guidelines adequate?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/380461" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Synergistic effects of ampicillin-aminoglycoside combinations on group B streptococci.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9099513" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Antibacterial therapy in pregnancy and neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1921490" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Cephalosporin antimicrobial agents and related compounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16396862" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
